MetLife Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$744K	Sell	38,808 -283	-0.7%	-$6.15K	﹤0.01%	1555
2025 Q4	$859K	Hold	39,091	–	–	﹤0.01%	1515
2025 Q3	$475K	Hold	39,091	–	–	﹤0.01%	1827
2025 Q2	$729K	Hold	39,091	–	–	﹤0.01%	1484
2025 Q1	$749K	Sell	39,091 -597	-2%	-$17.5K	﹤0.01%	1512
2024 Q4	$1.43M	Buy	39,688 +2,266	+6%	+$76.6K	0.01%	1239
2024 Q3	$1.59M	Buy	37,422 +21,086	+129%	+$894K	0.01%	1143
2024 Q2	$658K	Buy	16,336 +14,722	+912%	+$614K	﹤0.01%	1568
2024 Q1	$57.2K	Buy	1,614 +3	+0.2%	+$80	﹤0.01%	2697
2023 Q4	$47.7K	Sell	1,611 -28	-2%	-$581	﹤0.01%	2772
2023 Q3	$34K	Buy	1,639 +2	+0.1%	+$55	﹤0.01%	2856
2023 Q2	$40.2K	Sell	1,637 -2,062	-56%	-$66.3K	﹤0.01%	2906
2023 Q1	$150K	Sell	3,699 -39,146	-91%	-$1.62M	﹤0.01%	2379
2022 Q4	$1.93M	Sell	42,845 -864	-2%	-$39.1K	0.01%	922
2022 Q3	$2.09M	Sell	43,709 -324	-0.7%	-$17.8K	0.02%	853
2022 Q2	$2.61M	Buy	44,033 +375	+0.9%	+$30.8K	0.02%	786
2022 Q1	$5.08M	Buy	43,658 +12,869	+42%	+$1.5M	0.03%	519
2021 Q4	$4.63M	Buy	30,789 +509	+2%	+$68.7K	0.04%	437
2021 Q3	$3.61M	Buy	+30,280	New	+$3.34M	0.03%	538
2020 Q2	–	Sell	-23,636	Closed	-$1.52M	–	2355
2020 Q1	$1.52M	Sell	23,636 -1,198	-5%	-$83.9K	0.02%	715
2019 Q4	$1.48M	Hold	24,834	–	–	0.02%	930
2019 Q3	$1.46M	Hold	24,834	–	–	0.02%	902
2019 Q2	$1.6M	Buy	24,834 +2,128	+9%	+$137K	0.02%	907
2019 Q1	$1.44M	Hold	22,706	–	–	0.02%	939
2018 Q4	$862K	Hold	22,706	–	–	0.01%	1084
2018 Q3	$973K	Buy	+22,706	New	+$793K	0.01%	1136